Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/14/25 20:11 | 10/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 3 | S.dm | -4,452 | 48.49 | 0 | -92 | 526 | D | |||||||||||||||
10/9/25 18:58 | 9/8/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 4 | S.d | -1,768 | 46.47 | 0 | -38 | 167 | D | |||||||||||||||
10/3/25 16:30 | 9/2/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | 4 | S.d | -1,796 | 47.14 | 0 | -38 | 257 | D | |||||||||||||||
9/12/25 20:39 | 9/11/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 1 | S | -28 | 43.02 | 0 | -1 | 91 | D | |||||||||||||||
9/12/25 20:38 | 9/11/25 | AKRO | Health | Drug | Pharmaceutical Preparations | White William Richard | CA | O | CFO | 1 | S | -28 | 43.02 | 0 | -1 | 58 | D | |||||||||||||||
8/12/25 20:32 | 8/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Henderson Jane | CA | D | 1 | S.d | -142 | 47.46 | 0 | -3 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |